Literature DB >> 26400111

Colon cancer with unresectable synchronous metastases: the AAAP scoring system for predicting the outcome after primary tumour resection.

Z M Li1, Y F Peng1, C Z Du1, J Gu1.   

Abstract

AIM: The aim of this study was to develop a prognostic scoring system to predict the outcome of patients with unresectable metastatic colon cancer who received primary colon tumour resection.
METHOD: Patients with confirmed metastatic colon cancer treated at the Peking University Cancer Hospital between 2003 and 2012 were reviewed retrospectively. The correlation of clinicopathological factors with overall survival was analysed using the Kaplan-Meier method and the log-rank test. Independent prognostic factors were identified using a Cox proportional hazards regression model and were then combined to form a prognostic scoring system.
RESULTS: A total of 110 eligible patients were included in the study. The median survival time was 10.4 months and the 2-year overall survival (OS) rate was 21.8%. Age over 70 years, an alkaline phosphatase (ALP) level over 160 IU/l, ascites, a platelet/lymphocyte ratio (PLR) above 162 and no postoperative therapy were independently associated with a shorter OS in multivariate analysis. Age, ALP, ascites and PLR were subsequently combined to form the so-called AAAP scoring system. Patients were classified into high, medium and low risk groups according to the score obtained. There were significant differences in OS between each group (P < 0.001).
CONCLUSION: Age, ALP, ascites, PLR and postoperative therapy were independent prognostic factors for survival of patients with metastatic colonic cancer who underwent primary tumour resection. The AAAP scoring system may be a useful tool for surgical decision making. Colorectal Disease
© 2015 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Metastatic colorectal cancer; primary tumour resection; prognosis; risk ranking

Mesh:

Substances:

Year:  2016        PMID: 26400111     DOI: 10.1111/codi.13123

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  10 in total

1.  Multidisciplinary team intervention associated with improved survival for patients with colorectal adenocarcinoma with liver or lung metastasis.

Authors:  Chien-Hsin Chen; Mao-Chih Hsieh; Wilson T Lao; En-Kwang Lin; Yen-Jung Lu; Szu-Yuan Wu
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

2.  Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis.

Authors:  Zhan Yu; Zhen Chen; Jian Wu; Zhong Li; Yugang Wu
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

Review 3.  Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.

Authors:  Nan Chen; Wanling Li; Kexin Huang; Wenhao Yang; Lin Huang; Tianxin Cong; Qingfang Li; Meng Qiu
Journal:  Oncotarget       Date:  2017-05-09

Review 4.  An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.

Authors:  Xuan-Zhang Huang; Wen-Jun Chen; Xi Zhang; Cong-Cong Wu; Chao-Ying Zhang; Shuang-Shuang Sun; Jian Wu
Journal:  Dis Markers       Date:  2017-04-26       Impact factor: 3.434

5.  The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.

Authors:  Ya-Huan Guo; Hai-Feng Sun; Yan-Bing Zhang; Zi-Jun Liao; Lei Zhao; Jie Cui; Tao Wu; Jian-Rong Lu; Ke-Jun Nan; Shu-Hong Wang
Journal:  Oncotarget       Date:  2017-03-21

6.  Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.

Authors:  Ellen G Engelhardt; Dóra Révész; Hans J Tamminga; Cornelis J A Punt; Miriam Koopman; Bregje D Onwuteaka-Philipsen; Ewout W Steyerberg; Henrica C W de Vet; Veerle M H Coupé
Journal:  BMC Med Inform Decis Mak       Date:  2018-12-14       Impact factor: 2.796

Review 7.  The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis.

Authors:  Jinming Wang; Jing Li; Sheng Wei; Jie Xu; Xiaohui Jiang; Lei Yang
Journal:  Gastroenterol Res Pract       Date:  2021-11-02       Impact factor: 2.260

8.  Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.

Authors:  Xiaobin Gu; Xian-Shu Gao; Shangbin Qin; Xiaoying Li; Xin Qi; Mingwei Ma; Hao Yu; Shaoqian Sun; Dong Zhou; Wen Wang; Wei Xiong
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

9.  Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study.

Authors:  Dong S; Wang L; Guo Y B; Ying H F; Shen X H; Meng Z Q; Chen Hao; Chen Q W; Li Z S
Journal:  World J Surg Oncol       Date:  2017-07-03       Impact factor: 2.754

10.  Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer.

Authors:  Yi Yang; Yujie Lu; Wen Jiang; Jinzhou Zhu; Su Yan
Journal:  World J Surg Oncol       Date:  2020-08-03       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.